Related Experiment Videos
Generation and functional characterization of mouse monocyte-derived dendritic cells
M W Schreurs1, A A Eggert, A J de Boer
1Department of Tumor Immunology, University Hospital Nijmegen St. Radboud, Nijmegen, The Netherlands.
European Journal of Immunology
|October 3, 1999
Summary
Researchers generated mouse monocyte-derived dendritic cells (MODC) that mimic bone marrow-derived dendritic cells (DC). These MODC can initiate anti-tumor immunity, offering a new tool for cancer research.
Area of Science:
- Immunology
- Cell Biology
Background:
- Dendritic cells (DC) are crucial for initiating immune responses and are used in cancer immunotherapy.
- Different DC subsets may influence immune response outcomes.
- Mouse tumor models predominantly use bone marrow-derived DC, while human studies often use monocyte-derived DC.
Purpose of the Study:
- To generate and characterize mouse monocyte-derived DC (MODC).
- To compare mouse MODC with bone marrow-derived DC.
- To evaluate the potential of MODC in inducing anti-tumor immunity.
Main Methods:
- Generation of mouse MODC from peripheral blood monocytes using GM-CSF and IL-4.
- Phenotypic and functional characterization of MODC.
- Assessment of antigen uptake, cross-presentation, and T cell activation.
- In vivo vaccination studies using peptide-loaded MODC.
Main Results:
- Mouse MODC were successfully generated and exhibited similar morphology, phenotype, and immunostimulatory activity to bone marrow-derived DC.
- Both DC subsets efficiently presented protein antigens to cytotoxic T cells.
- Vaccination with peptide-loaded MODC induced tumor-reactive immunity in vivo.
Conclusions:
- Mouse MODC represent a viable alternative to bone marrow-derived DC for research.
- MODC can effectively induce anti-tumor immunity.
- This research provides a valuable tool for studying DC biology and optimizing DC-based cancer vaccines.